1. Yong D, Shin HB, Kim YK, Cho J, Lee WG, Ha GY, et al. Increase in the prevalence of carbapenem-resistant
Acinetobacter isolates and ampicillin-resistant non-typhoidal
Salmonella species in Korea: a KONSAR Study Conducted in 2011. Infect Chemother. 2014; 46:84–93. PMID:
25024870.
2. Chung HS, Lee Y, Park ES, Lee DS, Ha EJ, Kim M, et al. Characterization of the multidrug-resistant Acinetobacter species causing a nosocomial outbreak at intensive care units in a Korean Teaching Hospital: suggesting the correlations with the clinical and environmental samples, including respiratory tract-related instruments. Ann Clin Microbiol. 2014; 17:29–34.
3. Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R. Hospital outbreak of carbapenem-resistant
Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin Infect Dis. 2000; 31:1119–1125. PMID:
11073738.
4. Gregory CJ, Llata E, Stine N, Gould C, Santiago LM, Vazquez GJ, et al. Outbreak of carbapenem-resistant
Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol. 2010; 31:476–484. PMID:
20334553.
5. Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, et al. Outbreak of
Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother. 2004; 48:4793–4799. PMID:
15561858.
6. Gibb AP, Tribuddharat C, Moore RA, Louie TJ, Krulicki W, Livermore DM, et al. Nosocomial outbreak of carbapenem-resistant
Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7). Antimicrob Agents Chemother. 2002; 46:255–258. PMID:
11751148.
7. Tokatlidou D, Tsivitanidou M, Pournaras S, Ikonomidis A, Tsakris A, Sofianou D. Outbreak caused by a multidrug-resistant
Klebsiella pneumoniae clone carrying bla
VIM-12 in a university hospital. J Clin Microbiol. 2008; 46:1005–1008. PMID:
18199780.
8. Wrenn C, O'Brien D, Keating D, Roche C, Rose L, Ronayne A, et al. Investigation of the first outbreak of OXA-48-producing
Klebsiella pneumoniae in Ireland. J Hosp Infect. 2014; 87:41–46. PMID:
24746608.
9. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, et al. Risk factors for developing clinical infection with carbapenem-resistant
Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant
K pneumoniae. Am J Infect Control. 2012; 40:421–425. PMID:
21906844.
10. Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014; 20(Suppl 1):1–55. PMID:
24329732.
Article
11. Kim J, Lee JY, Kim SI, Song W, Kim JS, Jung S, et al. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant
Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med. 2014; 34:20–25. PMID:
24422191.
12. Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B. Fecal carriage of carbapenem-resistant
Enterobacteriaceae in a Chinese university hospital. Am J Infect Control. 2014; 42:e61–e64. PMID:
24773806.
13. Tenover FC, Canton R, Kop J, Chan R, Ryan J, Weir F, et al. Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay. J Clin Microbiol. 2013; 51:3780–3787. PMID:
24006011.
Article
14. Song W, Hong SG, Yong D, Jeong SH, Kim HS, Kim HS, et al. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing
Enterobacteriaceae and metallo-β-lactamase-producing
Pseudomonas spp. Ann Lab Med. 2015; 35:212–219. PMID:
25729723.
15. Lee W, Chung HS, Lee Y, Yong D, Jeong SH, Lee K, et al. Comparison of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry assay with conventional methods for detection of IMP-6, VIM-2, NDM-1, SIM-1, KPC-1, OXA-23, and OXA-51 carbapenemase-producing
Acinetobacter spp.,
Pseudomonas aeruginosa, and
Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 2013; 77:227–230. PMID:
23993215.
16. Park YJ, Song W. Strategies for interpretive standards of β-lactams susceptibility testing and identification of extended-spectrum β-lactamases and carbapenemases in Enterobacteriaceae. Ann Clin Microbiol. 2013; 16:111–119.
17. Seah C, Low DE, Patel SN, Melano RG. Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in
Enterobacteriaceae. J Clin Microbiol. 2011; 49:1965–1969. PMID:
21430097.
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility tsting. M100-S24. Wayne, PA: Clinical and Laboratory Standards Institues;2014.
19. Decousser JW, Poirel L, Desroches M, Jayol A, Denamur E, Nordmann P. Failure to detect carbapenem-resistant
Escherichia coli producing OXA-48-like using the Xpert Carba-R assay. Clin Microbiol Infect. 2015; 21:e9–e10. PMID:
25682281.